Financing, Equity Capital Markets

Allogene Therapeutics, Inc.

06/20
|
$632.5 Million
Piper Sandler served as bookrunner for Allogene Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma